Skip to content 
AMM 262: Stay Safe: Avoid the Trap of Counterfeit Botox
November 12, 2024
This episode explores the shift from surgical to non-invasive treatments in the medical aesthetics industry, highlighting Ulvera AI’s innovative technology. Dr. Ines Verner discusses how Ulvera AI’s Quazi Focus Ultrasound reduces body fat with minimal side effects, offering a new option for body contouring. The episode covers the science behind the technology, the ongoing clinical trials for FDA approval, and the impact of strategic backing from HiFund and HiCenter, positioning Ulvera AI for significant growth in the U.S. market. Listeners will gain insights into the future of non-invasive body treatments and the evolving landscape of medical aesthetics.
Quick Takes
- Ulvera AI is pioneering technology targeting body fat safely and effectively
- Quazi Focus Ultrasound technology developed by Ulvera AI promises significant results with minimal side effects
- HiFund and HiCenter are backing Ulvera AI’s U.S. launch with clinical trials aimed at securing FDA approval
Episode Transcript
Happy November 12th! In the ever-evolving landscape of medical aesthetics, the sector is witnessing a major shift from surgical to non-invasive treatments, now boasting an annual turnover of around $7.5 billion. Dr. Ines Verner, dermatologist and CEO of Ulvera AI, is at the forefront of this transformation. Ulvera AI is pioneering technology that targets body fat safely and effectively, focusing on areas like the abdomen and thighs.
With the help of Dr. Yoram Eshel and Dr. Boris Vaynberg, Ulvera AI has developed the Quazi Focus Ultrasound technology, which promises significant results with minimal side effects. This innovative approach induces apoptosis in fat cells, reducing circumference by up to 10 cm after three sessions. It’s a game-changer for those seeking body contouring without the pain or complications associated with traditional methods.
The partners at HiFund and HiCenter are backing Ulvera AI’s launch in the U.S., where clinical trials aim to secure FDA approval. As the market for non-invasive treatments burgeons, Ulvera AI’s groundbreaking technology and strong investor backing position it as a leader poised for significant growth. Keep an eye on this space as they aim to redefine non-invasive body contouring.
